Subscribe for Free (RSS + E-mail)

RSS + E-mail

XSITE 2013 →
Featured▾
- Napa Summit 2013 →
Xconomy National
Xperience
Tech + Life▾
- View More in Xperience ›
Our
Cities▾
Tech
Channels ▾
Meet the
Xconomists ▾
Our
Events ▾

bbigelow

Bruce V. Bigelow

Bruce Bigelow joins Xconomy from the business desk of the San Diego Union-Tribune. He was a member of the team of reporters who were awarded the 2006 Pulitzer Prize in National Reporting for uncovering bribes paid to San Diego Republican Rep. Randy “Duke” Cunningham in exchange for special legislation earmarks. He also shared a 2006 award for enterprise reporting from the Society of Business Editors and Writers for “In Harm’s Way,” an article about the extraordinary casualty rate among employees working in Iraq for San Diego’s Titan Corp. He has written extensively about the 2002 corporate accounting scandal at software goliath Peregrine Systems. He also was a Gerald Loeb Award finalist and National Headline Award winner for “The Toymaker,” a 14-part chronicle of a San Diego start-up company. He takes special satisfaction, though, that the series was included in the library for nonfiction narrative journalism at the Nieman Foundation for Journalism at Harvard University.

Bigelow graduated from U.C. Berkeley in 1977 with a degree in English Literature and from the Columbia University Graduate School of Journalism in 1979. Before joining the Union-Tribune in 1990, he worked for the Associated Press in Los Angeles and The Kansas City Times.

Recent posts

Wireless Health Summit Looks to “Engaged Consumer” to Drive Change

In the beginning, the Wireless Health Convergence Summit was viewed as a way to bring innovation to reality, according to Rob McCray, a co-founder and CEO of the San Diego-based Wireless... Read more »
San Diego Life Sciences Roundup: Effector, Ignyta, and More

A startup with a new approach to cancer drug development made its debut this week in San Diego. We’ve got the details, along with other local news in life sciences and... Read more »
Effector Therapeutics Raises $45M to Prove New Concept in Cancer

After Switzerland’s Roche paid $230 million in cash to buy San Diego’s Anadys Pharmaceuticals in 2011, Anadys CEO Steve Worland says he felt like an entrepreneur-in-residence, but without a venture capital... Read more »
ViaSat Plans to Boost Fast Growth with Second Internet Satellite

After 27 years as an unobtrusive specialist in satellite-based communications, Carlsbad, CA-based ViaSat (NASDAQ: VSAT) is acquiring a much bigger footprint.

While ViaSat has experienced plenty of success over the... Read more »
San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More

[Clarification 5/17/13, 2:05 pm. See below.] Right on the same line with the original lede so you don’t waste space on a carriage return…Antibody drugs seemed to be the... Read more »
San Diego’s AnaptysBio Gets BioDefense Contract for Ricin Antibodies

AnaptysBio says today the U.S. government has asked the San Diego biotech to produce antibodies that counter the deadly effects of ricin and would not require refrigeration, so batches of anti-ricin... Read more »
Ambit Slices Price of IPO, Increases Number of Shares Offered

San Diego’s Ambit Biosciences cut the share price of its planned IPO by nearly half yesterday, but still managed to raise about $65 million by increasing the number of shares in... Read more »
San Diego’s RuiYi (aka Anaphore) Focuses Anew on Antibodies & China

It’s been almost two years since Paul Grayson was named as CEO of San Diego’s Anaphore—more than enough time for the former Fate Therapeutics CEO to put a new strategy in... Read more »
Sorenson CEO Peter Csathy Goes Hollywood to Lead Manatt Venture Fund

Carlsbad, CA-based Sorenson Media CEO Peter Csathy tells me he’s left Sorenson to become CEO of Manatt Digital Media Ventures, a venture fund and digital media business created by the Manatt,... Read more »
Who Needs Equity Crowdfunding? Dealstruck Builds Crowdlending Market

After President Obama signed the JOBS Act more than a year ago, Ethan Senturia says he studied the provisions for crowdfunding startups under Title III, and came to the conclusion that... Read more »
Plug and Play Admits 8 San Diego Companies to Startup Camp

Eight seed-stage tech companies were selected late yesterday to be the first class of startups from San Diego to be admitted to the 10-week business technology accelerator program established by Silicon... Read more »
San Diego Life Sciences Roundup: Receptos, Arena, NuVasive, & More

Amid the hectic pace of earnings releases, we saw a number of partnership agreements and other developments coming out of San Diego’s life sciences community. Here’s my wrap-up.

—Shares of San... Read more »
Investors Step into Leadership at Corporate Ed-tech E-Learning Mind

Capas, a private investment firm established in Detroit last year, has acquired E-Learning Mind, a small San Diego ed-tech company that develops learning programs for corporate customers in such areas as... Read more »
Lumena Raises $23 Million to Advance Drug for Rare Liver Diseases

San Diego-based Lumena Pharmaceuticals says today it has raised $23 million in a Series A round that is intended to carry the company through mid-stage trials of its lead drug candidate... Read more »
San Diego’s Receptos, Ambit Biosciences, Get Ready for IPO Debuts

[Corrected 5/6/13, 10:50 am. See below.] San Diego-based Receptos, a biotech developing new treatments for immune disorders, is among 13 IPOs expected to go public this week, according to... Read more »
San Diego Life Sciences Roundup: Topera, Afraxis, Trovagene, & More

It was a week of deals, deals, and more deals for San Diego’s life sciences sector. Here’s my rundown.

—San Diego’s Abide Therapeutics entered into a drug development collaboration with Merck,... Read more »
Under Siege, San Diego’s Active Network Shuffles Leadership

Wow. The Active Network (NYSE: ACTV), the San Diego-based Web company that provides online registration and support for a host of recreational activities, is in the throes of a full-fledged... Read more »
Abide Therapeutics and Merck Unveil Diabetes Drug Collaboration

Abide Therapeutics, a two-year-old San Diego biopharmaceutical firm pioneering new ways to identify and validate drug targets among the serine hydrolase “superfamily” of enzymes, says today it has agreed to... Read more »
Automotive Cleantech Fallbrook Technologies Relocates Near Austin

Fallbrook Technologies was founded in San Diego, and it spent 15 years working to commercialize its design for a new type of continuously variable transmission, with the potential to increase fuel... Read more »
Seed Funding Enables GridCOM to Advance Cyber Security Technology

For the past couple of years, a variety of high-level federal officials have sounded increasingly urgent alarms about the vulnerabilities of the U.S. power grid to cyber attack.

In October, for... Read more »

Page 1 of 103 next page »